![]() | |
Names | |
---|---|
Preferred IUPAC name N,N-Diethyl-N-methyl-3-[(methylcarbamoyl)oxy]anilinium iodide | |
Other names AR-16, TL-1217 | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
PubChem CID | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C13H21IN2O2 | |
Molar mass | 364.227 g·mol−1 |
Related compounds | |
Related compounds | Neostigmine Miotine |
Hazards | |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose) | 129 μg/kg (Subcutaneous, mice) [1] 75 μg/kg (Subcutaneous, cats) [1] 75 μg/kg (Subcutaneous, dogs) [1] 150 μg/kg (Subcutaneous, rabbits) [1] 122.5 μg/kg (Intramuscular, rats) [2] |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
T-1123 is a carbamate-based acetylcholinesterase inhibitor. It was investigated as a chemical warfare agent starting in 1940. It does not go through the blood-brain barrier due to the charge on quaternary nitrogen. The antidote is atropine. [3] T-1123 is a quaternary ammonium ion. A phenyl carbamate ester is bonded in the meta position to the nitrogen on a diethylmethyl amine. The chloride and methylsulfate salt of T-1123 is TL-1299 and TL-1317, respectively.
T-1123 can be produced from m-diethylaminophenol, methyl isocyanate and methyl iodide. First, m-diethylaminophenol is reacted with methyl isocyanate to produce a methylcarbamate. The resulting methylcarbamate is then reacted with methyl iodide to produce T-1123. [1]